|
1
|
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline.
|
Arch Neurol
|
2002
|
4.60
|
|
2
|
Chronic dopaminergic stimulation in Parkinson's disease: from dyskinesias to impulse control disorders.
|
Lancet Neurol
|
2009
|
1.61
|
|
3
|
Evidence for a role of the rare p.A152T variant in MAPT in increasing the risk for FTD-spectrum and Alzheimer's diseases.
|
Hum Mol Genet
|
2012
|
1.46
|
|
4
|
Nocturia and overnight polysomnography in Parkinson disease.
|
Neurourol Urodyn
|
2013
|
1.40
|
|
5
|
Gait initiation and dynamic balance control in Parkinson's disease.
|
Arch Phys Med Rehabil
|
2005
|
1.32
|
|
6
|
Reliability of a new scale for essential tremor.
|
Mov Disord
|
2012
|
1.17
|
|
7
|
Gait initiation in older adults with postural instability.
|
Clin Biomech (Bristol, Avon)
|
2008
|
1.12
|
|
8
|
Resistance training with creatine monohydrate improves upper-body strength in patients with Parkinson disease: a randomized trial.
|
Neurorehabil Neural Repair
|
2007
|
1.09
|
|
9
|
Tourette syndrome deep brain stimulation: a review and updated recommendations.
|
Mov Disord
|
2014
|
1.02
|
|
10
|
The effect of Tai Chi exercise on gait initiation and gait performance in persons with Parkinson's disease.
|
Parkinsonism Relat Disord
|
2013
|
0.96
|
|
11
|
Progressive supranuclear palsy: a current review.
|
Neurologist
|
2008
|
0.94
|
|
12
|
Beneficial effects of testosterone replacement for the nonmotor symptoms of Parkinson disease.
|
Arch Neurol
|
2002
|
0.92
|
|
13
|
Aggregation of actin and cofilin in identical twins with juvenile-onset dystonia.
|
Ann Neurol
|
2002
|
0.89
|
|
14
|
Benefits and risks of pharmacological treatments for essential tremor.
|
Drug Saf
|
2003
|
0.88
|
|
15
|
Controlled pilot study of the effects of neuromuscular therapy in patients with Parkinson's disease.
|
Mov Disord
|
2006
|
0.87
|